Suven Life Sciences - Quaterly Results

13 May 2025 Evaluate
The Sales for the quarter ended March 2025 of Rs. 14.67 million declined by -38.49% from Rs. 23.85 millions.The Net Loss for the quarter ended March 2025 is Rs. -150.70 millions as compared to Net Loss of Rs. -31.25 millions of corresponding quarter ended March 2024 Operating profit Margin for the quarter ended March 2025 further decreased to -137.23% as compared to -25.87% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 14.67 23.85 -38.49 66.56 116.93 -43.08 66.56 116.93 -43.08
Other Income 11.91 42.83 -72.19 107.26 211.30 -49.24 107.26 211.30 -49.24
PBIDT -137.23 -25.87 430.46 -412.11 -98.07 320.22 -412.11 -98.07 320.22
Interest 0.00 0.30 0.00 0.47 1.58 -70.25 0.47 1.58 -70.25
PBDT -137.23 -26.17 424.38 -412.58 -25.08 1545.06 -412.58 -25.08 1545.06
Depreciation 13.47 15.10 -10.79 58.22 65.02 -10.46 58.22 65.02 -10.46
PBT -150.70 -41.27 265.16 -470.80 -90.10 422.53 -470.80 -90.10 422.53
TAX 0.00 -10.02 0.00 0.00 -10.02 0.00 0.00 -10.02 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -150.70 -31.25 382.24 -470.80 -80.08 487.91 -470.80 -80.08 487.91
Equity 218.07 218.07 0.00 218.07 218.07 0.00 218.07 218.07 0.00
PBIDTM(%) -935.45 -108.47 762.40 -619.16 -83.87 638.23 -619.16 -83.87 638.23

Suven Life Sciences Share Price

171.50 3.05 (1.81%)
12-Dec-2025 15:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.75
Dr. Reddys Lab 1278.80
Cipla 1517.95
Zydus Lifesciences 929.15
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×